Octane’s Ophthalmology Tech Forum (OTF)

Andrew Douglas, Robert Hilton, and Sophia Zahn will address considerations when using artificial intelligence in developing IP strategy related to ophthalmology as well as best practices in preparing for IP due diligence. The discussion will include breakout sessions for open discussion with the Knobbe Team. Octane’s Ophthalmology Tech Forum  brings together entrepreneurs, investors, and industry leaders to showcase advancements in ophthalmic innovation.